Literature DB >> 11933736

[Catamenial pneumothorax. Failure of videothorascopic treatment].

C Perrotin1, S Mussot, E Fadel, A Chapelier, P Dartevelle.   

Abstract

INTRODUCTION: Catamenial pneumothorax occurs in women during the menses. It is frequently associated with diaphragmatic fenestrations or episodes of pleural endometriosis. OBSERVATION: We report the case of a patients who had presented 25 episodes of right pneumothorax despite treatment with videothorascopy initiated after the 10th episode. These episodes coincided with menstruation. Diagnosis of catamenial pneumothorax was evoked and thoracic surgery was indicated. Exploration of the pleural fossa did not reveal symphysis but 7 diaphragmatic orifices, which were sutured before conducting mechanical pleurodesis. No relapse of pneumothorax was reported following surgery. COMMENTS: Around one hundred cases of catamenial pneumothorax have been reported in the literature. They represent 2.8 to 5.6% of spontaneous pneumothroax in women. Diagnosis is evoked on the occurrence of recurrent pneumothorax appearing 24 to 72 hours after the onset of menstruation. The pathogeny is uncertain and several mechanisms are frequently evoked. In the prevention of relapses, treatment consists in closing the diaphragmatic orifices with thoracotomy, resection of eventual bubbles, and pleural symphysis. Videothorascopy does not appear adapted to treatment.

Entities:  

Mesh:

Year:  2002        PMID: 11933736

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

Review 1.  Synchronous rectovaginal, urinary bladder, and pulmonary endometriosis.

Authors:  Georgios E Hilaris; Christopher K Payne; Joelle Osias; Walter Cannon; Camran R Nezhat
Journal:  JSLS       Date:  2005 Jan-Mar       Impact factor: 2.172

2.  Catamenial Pneumothorax as the First Expression of Thoracic Endometriosis Syndrome and Pelvic Endometriosis.

Authors:  Paola Ciriaco; Piergiorgio Muriana; Angelo Carretta; Jessica Ottolina; Massimo Candiani; Giampiero Negri
Journal:  J Clin Med       Date:  2022-02-23       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.